Skip to main content
All lobbying filings

Arnold & Porter Kaye Scholer LLP

Arnold & Porter Kaye Scholer LLP filed a Q2 report for Pharmaceutical Research and Manufacturers of America (PHRMA) on July 17, 2026, reporting $380,000 in lobbying income.

Lobbying for Pharmaceutical Research and Manufacturers of America (PHRMA)

As filed: ARNOLD & PORTER KAYE SCHOLER LLP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA).

All filings by Arnold & Porter Kaye Scholer LLP · Everything Pharmaceutical Research and Manufacturers of America (PHRMA) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$380,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbying activity 1

Issues related to various healthcare reform and drug pricing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem